Increased thalamic phospholipid concentration evident in bipolar I disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 41, Issue , 2013, Pages 1-5

  Howells, Fleur M ^a   Ives Deliperi, Victoria L ^a   Horn, Neil R ^a   Stein, Dan J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Bipolar disorder; Choline metabolites; Magnetic resonance spectroscopy; N acetyl aspartate; Phospholipids

Indexed keywords

CHOLINE; INOSITOL; N ACETYLASPARTIC ACID; PHOSPHOLIPID;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR I DISORDER; BRAIN SLICE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BRAIN LEVEL; MALE; METABOLITE; NEUROIMAGING; NEUROPATHOLOGY; PATIENT ASSESSMENT; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOLOGIC ASSESSMENT; THALAMOCORTICAL TRACT;

ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHOLIPIDS; THALAMUS; YOUNG ADULT;

EID: 84870833615     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.10.026     Document Type: Article

References (47)

1. Amaral J.A., Tamada R.S., Issler C.K., Caetano S.C., Cerri G.G., de Castro C.C., et al. A 1HMRS study of the anterior cingulate gyrus in euthymic bipolar patients. Hum Psychopharmacol 2006, 21:215-220.
2. Bertolino A., Frye M., Callicott J.H., Mattay V.S., Rakow R., Shelton-Repella J., et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003, 53:906-913.
3. Blasi G., Bertolino A., Brudaglio F., Sciota D., Altamura M., Antonucci N., et al. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Psychiatry Res 2004, 131:95-105.
4. Bokemeyer M., Ding X.Q., Goldbecker A., Raab P., Heeren M., Arvanitis D., et al. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. Gut 2011, 60:370-377.
5. Brambilla P., Stanley J.A., Sassi R.B., Nicoletti M.A., Mallinger A.G., Keshavan M.S., et al. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004, 29:1918-1924.
6. Brambilla P., Stanley J.A., Nicoletti M.A., Sassi R.B., Mallinger A.G., Frank E., et al. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 2005, 86:61-67.
7. Cecil K.M., DelBello M.P., Morey R., Strakowski S.M. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 2002, 4:357-365.
8. Clinton S.M., Meador-Woodruff J.H. Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 2004, 29:1353-1362.
9. Davanzo P., Thomas M.A., Yue K., Oshiro T., Belin T., Strober M., et al. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001, 24:359-369.
10. De Stefano N., Matthews P.M., Arnold D.L. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995, 34:721-727.
11. Deicken R.F., Pegues M.P., Anzalone S., Feiwell R., Soher B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 2003, 160:873-882.
12. Forester B.P., Finn C.T., Berlow Y.A., Wardrop M., Renshaw P.F., Moore C.M. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Bipolar Disord 2008, 10:691-700.
13. Frey B.N., Folgierini M., Nicoletti M., Machado-Vieira R., Stanley J.A., Soares J.C., et al. A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania. Hum Psychopharmacol 2005, 20:133-139.
14. Hamakawa H., Kato T., Murashita J., Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 1998, 248:53-58.
15. Howells F.M., Ives-Deliperi V.L., Horn N.R., Stein D.J. Mindfulness based cognitive therapy improves frontal control in bipolar disorder: a pilot EEG study. BMC Psychiatry 2012, 12:15.
16. Hurtado O., Pradillo J.M., Alonso-Escolano D., Lorenzo P., Sobrino T., Castillo J., et al. Neurorepair versus neuroprotection in stroke. Cerebrovasc Dis 2006, 21(Suppl. 2):54-63.
17. Jones E.G. Synchrony in the interconnected circuitry of the thalamus and cerebral cortex. Ann N Y Acad Sci 2009, 1157:10-23.
18. Kato T., Hamakawa H., Shioiri T., Murashita J., Takahashi Y., Takahashi S., et al. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996, 21:248-254.
19. Kato T., Inubushi T., Kato N. Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 1998, 10:133-147.
20. Meyerhoff D.J., MacKay S., Bachman L., Poole N., Dillon W.P., Weiner M.W., et al. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 1993, 43:509-515.
21. Moore G.J., Galloway M.P. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacol Bull 2002, 36:5-23.
22. Moore G.J., Bebchuk J.M., Hasanat K., Chen G., Seraji-Bozorgzad N., Wilds I.B., et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biol Psychiatry 2000, 48:1-8.
23. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998, 95:13290-13295.
24. Patel T.B., Clark J.B. Synthesis of N-acetyl-l-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 1979, 184:539-546.
25. Perry W., Minassian A., Feifel D., Braff D.L. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry 2001, 50:418-424.
26. Provencher S. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993, 30:672.
27. Ross B., Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994, 10:191-247.
28. Sarnthein J., Jeanmonod D. High thalamocortical theta coherence in patients with neurogenic pain. Neuroimage 2008, 39:1910-1917.
29. Sarnthein J., Morel A., von Stein A., Jeanmonod D. Thalamocortical theta coherence in neurological patients at rest and during a working memory task. Int J Psychophysiol 2005, 57:87-96.
30. Senaratne R., Milne A.M., MacQueen G.M., Hall G.B. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res 2009, 172:205-209.
31. Shimizu H., Shirane R., Fujiwara S., Takahashi A., Yoshimoto T. Proton magnetic resonance spectroscopy in children with moyamoya disease. Clin Neurol Neurosurg 1997, 99(Suppl. 2):S64-S67.
32. Shimon H., Agam G., Belmaker R.H., Hyde T.M., Kleinman J.E. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 1997, 154:1148-1150.
33. Silverstone P.H., Wu R.H., O'Donnell T., Ulrich M., Asghar S.J., Hanstock C.C. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 2003, 18:73-79.
34. Silverstone P.H., McGrath B.M., Kim H. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord 2005, 7:1-10.
35. 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005, 30:1949-1962.
36. Steriade M. Presynaptic dendrites of thalamic local-circuit neurons and sculpting inhibition during activated states. J Physiol 2003, 546:137-148.
37. Steriade M. Local gating of information processing through the thalamus. Neuron 2004, 41:493-494.
38. Stoll A.L., Renshaw P.F., Sachs G.S., Guimaraes A.R., Miller C., Cohen B.M., et al. The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1992, 32:944-949.
39. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005, 10:900-919.
40. Truckenmiller M.E., Namboodiri M.A., Brownstein M.J., Neale J.H. N-Acetylation of l-aspartate in the nervous system: differential distribution of a specific enzyme. J Neurochem 1985, 45:1658-1662.
41. Urosevic S., Abramson L.Y., Harmon-Jones E., Alloy L.B. Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence. Clin Psychol Rev 2008, 28:1188-1205.
42. Vion-Dury J., Meyerhoff D.J., Cozzone P.J., Weiner M.W. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?. J Neurol 1994, 241:354-371.
43. Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., Ketter T.A. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000, 47:475-481.
44. WMA General Assembly World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000 2000.
45. Wu R.H., O'Donnell T., Ulrich M., Asghar S.J., Hanstock C.C., Silverstone P.H. Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate. Ann Gen Hosp Psychiatry 2004, 3:13.
46. Yildiz-Yesiloglu A., Ankerst D.P. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:969-995.
47. Zimmerman R.A., Wang Z.J. The value of proton MR spectroscopy in pediatric metabolic brain disease. AJNR Am J Neuroradiol 1997, 18:1872-1879.